Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 106

1.

Early human screening of medications to treat drug addiction: novel paradigms and the relevance of pharmacogenetics.

Perkins KA, Lerman C.

Clin Pharmacol Ther. 2011 Mar;89(3):460-3. doi: 10.1038/clpt.2010.254. Epub 2011 Jan 26. No abstract available.

PMID:
21270792
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Editorial: clinical use of biomarkers in drug metabolism and adverse drug reactions.

Agundez JA.

Curr Drug Metab. 2014 Feb;15(2):127-8. No abstract available.

PMID:
24655066
[PubMed - indexed for MEDLINE]
3.

Pharmacogenetics of drugs withdrawn from the market.

Zhang W, Roederer MW, Chen WQ, Fan L, Zhou HH.

Pharmacogenomics. 2012 Jan;13(2):223-31. doi: 10.2217/pgs.11.137.

PMID:
22256871
[PubMed - indexed for MEDLINE]
4.

The future of biomarkers.

Aruoma OI, Bahorun T.

Toxicology. 2010 Dec 5;278(2):161-4. doi: 10.1016/j.tox.2010.09.015. Epub 2010 Oct 1. No abstract available.

PMID:
20888386
[PubMed - indexed for MEDLINE]
5.

Pharmacogenetics and stroke.

Meschia JF.

Stroke. 2009 Nov;40(11):3641-5. doi: 10.1161/STROKEAHA.109.562231. Epub 2009 Sep 17. Review.

PMID:
19762696
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

The role of human drug self-administration procedures in the development of medications.

Comer SD, Ashworth JB, Foltin RW, Johanson CE, Zacny JP, Walsh SL.

Drug Alcohol Depend. 2008 Jul 1;96(1-2):1-15. doi: 10.1016/j.drugalcdep.2008.03.001. Epub 2008 Apr 24. Review.

PMID:
18436394
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Symbiotic relationship of pharmacogenetics and drugs of abuse.

Rutter JL.

AAPS J. 2006 Mar 24;8(1):E174-84. Review.

PMID:
16584126
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Pharmacogenetics of drug dependence: role of gene variations in susceptibility and treatment.

Khokhar JY, Ferguson CS, Zhu AZ, Tyndale RF.

Annu Rev Pharmacol Toxicol. 2010;50:39-61. doi: 10.1146/annurev.pharmtox.010909.105826. Review.

PMID:
20055697
[PubMed - indexed for MEDLINE]
9.

[Pharmacogenetics and the treatment of addiction].

Schellekens A.

Ned Tijdschr Geneeskd. 2013;157(23):A5725. Review. Dutch.

PMID:
23739600
[PubMed - indexed for MEDLINE]
10.

Breaking barriers in the genomics and pharmacogenetics of drug addiction.

Ho MK, Goldman D, Heinz A, Kaprio J, Kreek MJ, Li MD, Munafò MR, Tyndale RF.

Clin Pharmacol Ther. 2010 Dec;88(6):779-91. doi: 10.1038/clpt.2010.175. Epub 2010 Oct 27. Review.

PMID:
20981002
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Promise of new translational safety biomarkers in drug development and challenges to regulatory qualification.

Sistare FD, DeGeorge JJ.

Biomark Med. 2011 Aug;5(4):497-514. doi: 10.2217/bmm.11.52. Review.

PMID:
21861671
[PubMed - indexed for MEDLINE]
12.

Human microdosing; a boon or a bane?

Seth SD, Kumar NK, Dua P.

Indian J Med Res. 2009 Aug;130(2):202-4. No abstract available.

PMID:
19797820
[PubMed - indexed for MEDLINE]
13.

Clinically relevant genetic variations in drug metabolizing enzymes.

Pinto N, Dolan ME.

Curr Drug Metab. 2011 Jun;12(5):487-97. Review.

PMID:
21453273
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Identifying genomic and developmental causes of adverse drug reactions in children.

Becker ML, Leeder JS.

Pharmacogenomics. 2010 Nov;11(11):1591-602. doi: 10.2217/pgs.10.146. Review.

PMID:
21121777
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

The pharmacogenetics research network: from SNP discovery to clinical drug response.

Giacomini KM, Brett CM, Altman RB, Benowitz NL, Dolan ME, Flockhart DA, Johnson JA, Hayes DF, Klein T, Krauss RM, Kroetz DL, McLeod HL, Nguyen AT, Ratain MJ, Relling MV, Reus V, Roden DM, Schaefer CA, Shuldiner AR, Skaar T, Tantisira K, Tyndale RF, Wang L, Weinshilboum RM, Weiss ST, Zineh I; Pharmacogenetics Research Network.

Clin Pharmacol Ther. 2007 Mar;81(3):328-45. Review.

PMID:
17339863
[PubMed - indexed for MEDLINE]
16.

A generic operational strategy to qualify translational safety biomarkers.

Matheis K, Laurie D, Andriamandroso C, Arber N, Badimon L, Benain X, Bendjama K, Clavier I, Colman P, Firat H, Goepfert J, Hall S, Joos T, Kraus S, Kretschmer A, Merz M, Padro T, Planatscher H, Rossi A, Schneiderhan-Marra N, Schuppe-Koistinen I, Thomann P, Vidal JM, Molac B.

Drug Discov Today. 2011 Jul;16(13-14):600-8. doi: 10.1016/j.drudis.2011.04.011. Epub 2011 May 6. Review.

PMID:
21570476
[PubMed - indexed for MEDLINE]
17.

What will be the role of pharmacogenetics in evaluating drug safety and minimising adverse effects?

Ozdemir V, Shear NH, Kalow W.

Drug Saf. 2001;24(2):75-85. Review.

PMID:
11235820
[PubMed - indexed for MEDLINE]
18.

Whole-genome sequencing in pharmacogenetics.

Urban TJ.

Pharmacogenomics. 2013 Mar;14(4):345-8. doi: 10.2217/pgs.12.211. No abstract available.

PMID:
23438878
[PubMed - indexed for MEDLINE]
19.

Progressing the utilisation of pharmacogenetics and pharmacogenomics into clinical care.

Trent RJ, Cheong PL, Chua EW, Kennedy MA.

Pathology. 2013 Jun;45(4):357-70. doi: 10.1097/PAT.0b013e328360b66e. Review.

PMID:
23594690
[PubMed - indexed for MEDLINE]
20.

Pharmacogenomic importance of ABCG2.

Cusatis G, Sparreboom A.

Pharmacogenomics. 2008 Aug;9(8):1005-9. doi: 10.2217/14622416.9.8.1005. Review.

PMID:
18681776
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk